Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Convertible Debt (2021 - 2026)

SkinHealth Systems has reported Convertible Debt over the past 5 years, most recently at $364.4 million for Q4 2025.

  • Quarterly Convertible Debt fell 34.01% to $364.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $364.4 million through Dec 2025, down 34.01% year-over-year, with the annual reading at $364.4 million for FY2025, 34.01% down from the prior year.
  • Convertible Debt was $364.4 million for Q4 2025 at SkinHealth Systems, roughly flat from $363.4 million in the prior quarter.
  • Over five years, Convertible Debt peaked at $738.4 million in Q4 2023 and troughed at $363.1 million in Q2 2025.
  • The 5-year median for Convertible Debt is $729.4 million (2021), against an average of $627.8 million.
  • Year-over-year, Convertible Debt grew 0.58% in 2022 and then crashed 34.1% in 2025.
  • A 5-year view of Convertible Debt shows it stood at $729.9 million in 2021, then increased by 0.58% to $734.1 million in 2022, then increased by 0.58% to $738.4 million in 2023, then decreased by 25.21% to $552.2 million in 2024, then crashed by 34.01% to $364.4 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Convertible Debt are $364.4 million (Q4 2025), $363.4 million (Q3 2025), and $363.1 million (Q2 2025).